• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[接受心脏再同步治疗除颤器（CRT-D）且出现进行性心力衰竭症状的患者]

[Patient with a defibrillator for cardiac resynchronization therapy (CRT-D) and progressive symptoms of heart failure].

作者信息

Bosch Ralph

机构信息

Cardio Centrum Ludwigsburg-Bietigheim (CCLB), Asperger Str. 48, 71634, Ludwigsburg, Deutschland.

出版信息

Herzschrittmacherther Elektrophysiol. 2021 Dec;32(4):492-499. doi: 10.1007/s00399-021-00825-9. Epub 2021 Nov 8.

DOI:10.1007/s00399-021-00825-9
PMID:34748046
Abstract

A 73-year-old woman with advanced heart failure experienced a deterioration of symptoms and left ventricular function despite treatment with cardiac resynchronization therapy (CRT). The cause was diagnosed by 12-lead ECG and corrected by reprogramming, which led to an improvement in symptoms and echocardiography.

摘要

一名73岁的晚期心力衰竭女性患者，尽管接受了心脏再同步治疗（CRT），症状仍出现恶化，左心室功能也有所下降。病因通过12导联心电图得以诊断，并通过重新编程进行了纠正，这使得症状和超声心动图结果均得到改善。

相似文献

1
[Patient with a defibrillator for cardiac resynchronization therapy (CRT-D) and progressive symptoms of heart failure].[接受心脏再同步治疗除颤器（CRT-D）且出现进行性心力衰竭症状的患者]
Herzschrittmacherther Elektrophysiol. 2021 Dec;32(4):492-499. doi: 10.1007/s00399-021-00825-9. Epub 2021 Nov 8.
2
Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).比较低脉压（<40mmHg）与高脉压（>40mmHg）对预测心力衰竭心脏再同步治疗获益的价值（来自多中心自动除颤器植入试验-心脏再同步治疗试验）。
Am J Cardiol. 2014 Oct 1;114(7):1053-8. doi: 10.1016/j.amjcard.2014.07.014. Epub 2014 Jul 17.
3
Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.采用一套新型检测算法减少心脏再同步治疗除颤器治疗的心力衰竭患者不适当的抗心动过速起搏治疗和电击：前瞻性数据库的历史对照研究
Europace. 2016 Sep;18(9):1391-8. doi: 10.1093/europace/euv420. Epub 2016 Jan 29.
4
A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.一项随机研究：心脏再同步治疗除颤器与双腔植入式心脏复律除颤器在伴有窄 QRS 波的缺血性心肌病中的应用：NARROW-CRT 研究。
Circ Arrhythm Electrophysiol. 2013 Jun;6(3):538-45. doi: 10.1161/CIRCEP.113.000135. Epub 2013 Apr 16.
5
The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).心脏再同步治疗除颤器与植入式心脏复律除颤器患者中，间歇性房性快速心律失常对心力衰竭或死亡的影响：MADIT-CRT 亚研究（多中心自动除颤器植入试验与心脏再同步治疗）。
J Am Coll Cardiol. 2014 Apr 1;63(12):1190-1197. doi: 10.1016/j.jacc.2013.10.074. Epub 2013 Dec 11.
6
Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).心脏再同步治疗可降低 MADIT-CRT（心脏再同步治疗的多中心自动除颤器植入试验）中的左心房容积和房性快速性心律失常的风险。
J Am Coll Cardiol. 2011 Oct 11;58(16):1682-9. doi: 10.1016/j.jacc.2011.07.020.
7
Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.心脏再同步治疗可减少原发性而非继发性预防性植入式心律转复除颤器患者的室性心律失常：来自门诊心力衰竭试验中再同步治疗的见解。
Circ Arrhythm Electrophysiol. 2017 Mar;10(3). doi: 10.1161/CIRCEP.116.004875.
8
Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.心脏再同步治疗可降低心力衰竭患者的 T 波交替。
Europace. 2015 Feb;17(2):281-8. doi: 10.1093/europace/euu258. Epub 2014 Nov 14.
9
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).多中心自动除颤器植入试验-心脏再同步治疗（MADIT-CRT）中 QRS 形态对心脏再同步治疗效果的影响。
Circulation. 2011 Mar 15;123(10):1061-72. doi: 10.1161/CIRCULATIONAHA.110.960898. Epub 2011 Feb 28.
10
Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.心房和室性早搏的频率与双心室起搏比例与心脏再同步治疗患者预后的关系。
J Am Coll Cardiol. 2014 Sep 9;64(10):971-81. doi: 10.1016/j.jacc.2014.06.1177.

本文引用的文献

1
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology.心脏再同步治疗的优化实施：呼吁采取行动以转诊和优化治疗：心力衰竭协会（HFA）、欧洲心律协会（EHRA）和欧洲心脏病学会的心血管影像协会（EACVI）的联合立场声明。
Eur J Heart Fail. 2020 Dec;22(12):2349-2369. doi: 10.1002/ejhf.2046.
2
Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing.适应反应试验的原理和设计：心脏再同步治疗中优先适应性左心室单独起搏的前瞻性随机研究。
Eur J Heart Fail. 2017 Jul;19(7):950-957. doi: 10.1002/ejhf.895.
3
Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial.收缩性传感器指导下的心脏再同步治疗优化：RESPOND-CRT 试验结果。
Eur Heart J. 2017 Mar 7;38(10):730-738. doi: 10.1093/eurheartj/ehw526.
4
Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients.丧失心脏再同步治疗起搏的原因：来自 32844 例患者的见解。
Circ Arrhythm Electrophysiol. 2012 Oct;5(5):884-8. doi: 10.1161/CIRCEP.112.973776. Epub 2012 Aug 26.
5
Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial.探讨一种新型的左心室同步起搏算法和心脏再同步治疗的动态优化：适应性 CRT 试验结果。
Heart Rhythm. 2012 Nov;9(11):1807-14. doi: 10.1016/j.hrthm.2012.07.009. Epub 2012 Jul 14.
6
Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival.心脏再同步治疗与双心室起搏百分比与症状和生存的关系。
Heart Rhythm. 2011 Sep;8(9):1469-75. doi: 10.1016/j.hrthm.2011.04.015. Epub 2011 Apr 15.
7
Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.主要结果来自 SmartDelay 确定的房室（AV）优化：与心脏再同步治疗（CRT）中使用的其他 AV 延迟方法的比较（SMART-AV）试验：一项比较经验性、超声心动图指导和算法性房室延迟编程在心脏再同步治疗中的随机试验。
Circulation. 2010 Dec 21;122(25):2660-8. doi: 10.1161/CIRCULATIONAHA.110.992552. Epub 2010 Nov 15.
8
The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy.12导联动态心电图监测在永久性心房颤动患者中用于识别心脏再同步治疗后无反应者的效用。
J Am Coll Cardiol. 2009 Mar 24;53(12):1050-5. doi: 10.1016/j.jacc.2008.12.022.
9
Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.作为心力衰竭疾病管理项目一部分的心脏再同步优化诊所的见解。
J Am Coll Cardiol. 2009 Mar 3;53(9):765-73. doi: 10.1016/j.jacc.2008.11.024.
10
Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?心力衰竭失代偿及全因死亡率与心力衰竭患者双心室起搏百分比的关系：双心室起搏达到100%的目标是否必要？
J Am Coll Cardiol. 2009 Jan 27;53(4):355-60. doi: 10.1016/j.jacc.2008.09.043.